Rosiglitazone appears to improve cognition in patients with Alzheimer's disease who do not possess an ApoE4 gene variant

By  

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Understanding the relationship between ApoE and HSV-1 and its possible significance in Alzheimer’s disease

By Burgos Javier S   Valdivieso Fernando  

Future Virology, Vol. 2, Iss. 3, 2007-05 ,pp. : 239-242

Future Medicine

Access to resources Recommend Favorite

Apolipoprotein E4 (ApoE4) genotype and/or gender do not appear to predict a response to donepezil in patients with mild-to-moderate Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model

By Borroni B.   Colciaghi F.   Pastorino L.   Archetti S.   Corsini P.   Cattabeni F.   Di Luca M.   Padovani A.  

European Neuropsychopharmacology, Vol. 12, Iss. 3, 2002-06 ,pp. : 195-200

Elsevier

Access to resources Recommend Favorite

Cholesterol and Apoe: A Target for Alzheimer's Disease Therapeutics

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 553-567

Bentham Science Publishers

Access to resources Recommend Favorite